SCHEMBL214633

SCHEMBL214633

[S]C(=S)N1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11464823 0.97
SCHEMBL11382430 0.97 CA1 (0.55)
SCHEMBL2858061 0.79
SCHEMBL187410 0.76 CA1 (0.55)
SCHEMBL2442152 0.76
SCHEMBL1274411 0.74 ALDH1A1 (0.59)
Hydrochloric Acid SCHEMBL11848293 0.73 CA1 (0.52)
Methane SCHEMBL27649004 0.73 CA1 (0.52)
Pyrrolidine Dithiocarbamate SCHEMBL322100 0.71
SCHEMBL1276482 0.71 CA1 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1980000537-A1 PYRIMIDO(1,6-A)INDOLE DERIVATIVES AMERICAN HOME PROD (US) 1980-04-03 WO claimed
EP-0008950-A2 Pyrimido(1,6-a)indole derivatives and intermediates therefor, processes for their preparation, pharmaceutical compositions containing the derivatives and their use AMERICAN HOME PRODUCTS CORPORATION (US) 1980-03-19 EP claimed
US-20120046276-A1 Tuberculosis treatment using pleuromutilin derivatives NABRIVA THERAPEUTICS AG (AT) 2012-02-23 US disclosed
US-8088823-B2 Tuberculosis treatment using pleuromutilin derivatives NABRIVA THERAPEUTICS AG (AT) 2012-01-03 US disclosed
EP-1501495-B1 USE OF PLEUROMUTILINS FOR THE TREATMENT OF DISORDERS CAUSED BY HELICOBACTER PYLORI NABRIVA THERAPEUTICS AG (AT) 2010-09-08 EP disclosed
US-7790749-B2 Use of pleuromutilins for the treatment of disorders caused by Helicobacter pylori NABRIVA THERAPEUTICS AG (AT) 2010-09-07 US disclosed
EP-1875903-A1 TUBERCULOSIS TREATMENT USING PLEUROMUTILIN DERIVATIVES Nabriva Therapeutics Forschungs GmbH (AT) 2008-01-09 EP disclosed
US-20070270404-A1 Tuberculosis treatment using pleuromutilin derivatives NABRIVA THERAPEUTICS FORSCHUNGS GMBH (AT) 2007-11-22 US disclosed
US-20050215637-A1 Tuberculosis treatment ASCHER GERD 2005-09-29 US disclosed
US-20050131023-A1 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD. (CN) 2005-06-16 US disclosed
EP-1501495-A1 USE OF PLEUROMUTILINS FOR THE TREATMENT OF DISORDERS CAUSED BY HELICOBACTER PYLORI Sandoz AG (CH) 2005-02-02 EP disclosed
US-4409224-A Pyrimido[1,6-a]indole derivatives AMERICAN HOME PRODUCTS CORP. (US) 1983-10-11 US disclosed
US-4310590-A BACTERICIDES, FUNGICIDES ROHM AND HAAS COMPANY (US) 1982-01-12 US disclosed
US-4307234-A Pyrimido[1,6-a]indole derivatives AMERICAN HOME PRODUCTS CORP. (US) 1981-12-22 US disclosed
EP-0031705-A1 Substituted 3-isothiazolones, salts and metal salt complexes thereof, compositions containing them and their use for combating bacteria, algae and fungi ROHM AND HAAS COMPANY (US) 1981-07-08 EP disclosed
WO-1980000537-A1 PYRIMIDO(1,6-A)INDOLE DERIVATIVES AMERICAN HOME PROD (US) 1980-04-03 WO disclosed
EP-0008950-A2 Pyrimido(1,6-a)indole derivatives and intermediates therefor, processes for their preparation, pharmaceutical compositions containing the derivatives and their use AMERICAN HOME PRODUCTS CORPORATION (US) 1980-03-19 EP disclosed
US-4060542-A 14-Desoxy-14 thiocyanato-acetoxy-mutilin BIOCHEMIE GESELLSCHAFT M.B.H. (OE) 1977-11-29 US disclosed
US-3979423-A FEED ADDITIVES BIOCHEMIE GESELLSCHAFT M.B.H. (OE) 1976-09-07 US disclosed
US-3979423-A FEED ADDITIVES BIOCHEMIE GESELLSCHAFT M.B.H. (OE) 1976-09-07 US disclosed